Health Technology Assessment

2012

Carlos Alves, Francisco Batel Marques, Ana Filipa Macedo A meta-analysis of serious adverse events reported with exenatide and liraglutide: Acute pancreatitis and cancer Diabetes Res Clin Pract 2012;98(2):271-84 [more info]

Diogo Mendes, Carlos Alves, Francisco Batel Marques Nurses’ spontaneous reporting of adverse drug reactions: expert review of routine reports Journal of Nursing Management 2012 DOI: 10.1111/jonm.12003 [more info]

Lima LMAV, Craveiro N, Dias PGP, and Batel Marques FJ Implemented Data Mining and Signal Management Systems on Spontaneous Reporting Systems’ Databases and their Availability to the Scientific Community - A Systematic Review Curr Drug Saf. 2012;7(2):170-5 [more info]

Diogo Mendes, Carlos Alves, Francisco Batel Marques Iatrogenia grave desconhecida, notificações e notificadores: resultados da actividade da Unidade de Farmacovigilância do Centro Rev Port Med Geral Fam 2012;28:34-40 [more info]

2011

Alves C., Batel-Marques F., Macedo A.F. Apixaban and rivaroxaban safety after hip and knee arthroplasty: a meta-analysis. J Cardiovasc Pharmacol Therap [Epub ahead of print 1Dec2011] doi: 10.1177/1074248411427402 [more info]

Feio J., Batel Marques F., Figueiredo A. Medicamentos: novidade, inovação e necessidade. Cadernos Saúde e Sociedade 2011; 1021:97-102 [more info]

Alves C, Batel Marques F, Macedo AF Data sources on drug safety evaluation: a review of recent published meta-analysis. Pharmacoepidemiol Drug Saf 2012;21(1):21-33 [more info]

Batel Marques F, Cunha Vaz J Prescrição de Medicamentos Off-Label. Rev Port Farmacoter 2011;3:169-171 [more info]

Batel Marques F Política do Medicamento. Rev Port Farmacoter 2011;3:165-168 [more info]

Silva V, Pita Barros P, Lourenço O, Batel-Marques F. Fecundação in vitro em Portugal: um estudo de custo-efectividade. Rev Port Farmacoter 2011;3:139-153 [more info]